Overview

PENG Block for Arthroscopic Hip Surgery

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
0
Participant gender:
All
Summary
This randomized, double-blinded, placebo-controlled trial seeks to evaluate the analgesic efficacy of the pericapsular nerve group block in the setting of outpatient hip arthroscopy.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Virginia
Treatments:
Ropivacaine
Criteria
Inclusion Criteria:

- Patients > 18 years old undergoing unilateral hip arthroscopy at the outpatient
surgery center.

Exclusion Criteria:

- refusal to participate

- < 18 yo

- Chronic opioid use

- localized infection